QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.063222v1 309/2/469    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Banks, W. A. Articles by Niehoff, M. L. Search for Related Content PubMed PubMed Citation Articles by Banks, W. A. Articles by Niehoff, M. L. Pubmed/NCBI databases Substance via MeSH Hazardous Substances DB GLUCAGON

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center-St. Louis, St. Louis, Missouri (W.A.B., M.L.N.); Saint Louis University School of Medicine, Division of Geriatrics; Department of Internal Medicine, St. Louis, Missouri (W.A.B., M.L.N.); and Department of Molecular Medicine and Pathology; University of Aukland, Auckland, New Zealand (M.J.D.)

Exendin, a member of the glucagon-like peptide-1 family, and its antagonist exendin(9-39) affect cognition and neuronal survival after their intranasal delivery. Here, we examined the uptake of radioactively labeled exendin(9-39) (I-Ex) by the olfactory bulbs, brain (minus pineal, pituitary, and olfactory bulb), cerebrospinal fluid, and cervical lymph nodes (C-node) as well as levels in serum after intranasal or intravenous administration. We found that olfactory bulb uptake of I-Ex after intranasal administration was rapid, much greater than after i.v. administration, and was enhanced by about 60% with cyclodextrin (CD). I-Ex was also taken up by the remainder of the brain after intranasal administration, but this uptake was not enhanced by CD, nor did it exceed uptake after i.v. administered I-Ex. Uptake by the olfactory bulb was not dependent on Brownian motion but did involve active processes. Intranasal I-Ex reached the C-node by way of the blood. About one-sixth of the intranasal dose of I-Ex entered the blood. However, the vascular route accounted for little of the intranasal I-Ex that reached the brain and even less that reached the olfactory bulb. I-Ex after intranasal administration was found in the hippocampus, cerebellum, brain stem, and cerebrospinal fluid (CSF). Distribution patterns showed that intranasal I-Ex used the extraneuronal route of CSF rather than brain parenchyma to diffuse throughout the brain. These results show that intranasal administration is an effective means of delivering peptide to the brain, especially the olfactory bulb.

Address correspondence to: Dr. William A. Banks, 915 N. Grand Blvd., St. Louis, MO 63106. E-mail: bankswa{at}slu.edu

This article has been cited by other articles:

				N. Nonaka, S. A. Farr, H. Kageyama, S. Shioda, and W. A. Banks Delivery of Galanin-Like Peptide to the Brain: Targeting with Intranasal Delivery and Cyclodextrins J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 513 - 519. [Abstract] [Full Text] [PDF]

				B. Perras, B. Schultes, B. Behn, C. Dodt, J. Born, and H. L. Fehm Intranasal Atrial Natriuretic Peptide Acts as Central Nervous Inhibitor of the Hypothalamo-Pituitary-Adrenal Stress System in Humans J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4642 - 4648. [Abstract] [Full Text] [PDF]